Déjà vu all over again: Another year passes without approval of new suppliers of marijuana for research
WASHINGTON — Forgive us if you read our stories on this topic from 2017 and 2018, but here it comes again: Another year has passed since the Drug Enforcement Administration said it was open to approving more suppliers of marijuana for scientific research, and another year has passed without an application being approved.
The lag has increasingly frustrated scientists, advocates, and members of Congress from both parties who argue that expanding research into marijuana could lead to new medicines and help identify what health risks use presents.
